AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Comparing CAR-T Therapies and Discussing Patient Populations
In this chapter, the speakers discuss the potential superiority of Lita sell compared to Ida sell, but express concern over the neurotoxicity associated with Silta sell, as well as the high non-relapse mortality shown in a meta analysis presented at ASH. They also discuss the impact of eligibility criteria on the outcomes of CAR-T therapies and express gratitude towards the guest speaker.